Five things for pharma marketers to know: Wednesday, April 5, 2023

Arbutus Biopharma sues Pfizer and BioNTech over COVID-19 vaccine patent infringement claims; Biogen appoints Adam Keeney as its head of corporate development.

Related Keywords

New Jersey ,United States ,Adam Keeney ,Chris Viehbacher ,Reuters ,Pfizer ,Arbutus Biopharma ,Endpoints News ,